Citi Starts Keryx Biopharmaceuticals (KERX) at Sell
Tweet
Share
E-mailGet Alerts KERX Hot Sheet
Price: $3.36 --0%
Rating Summary:
6 Buy, 10 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 20
Rating Summary:
6 Buy, 10 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 4 | New: 20
Join SI Premium – FREE
Citi initiated coverage on Keryx Biopharmaceuticals (NASDAQ: KERX) with a Sell rating and a price target of $1.50.
For an analyst ratings summary and ratings history on Keryx Biopharmaceuticals click here. For more ratings news on Keryx Biopharmaceuticals click here.
Shares of Keryx Biopharmaceuticals closed at $6.03 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Needham Starts Red Violet (RDVT) at Buy, 'offers the leading Cloud identity intelligence platform in the market today'
- Deutsche Bank Starts SPIE SA (SPIE:FP) (SPIWF) at Buy
- Rosenblatt Starts Booking Holdings (BKNG) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
